Advertisement

Topics

Cambridge Investment Research Ltd Company Profile

09:00 EDT 24th June 2018 | BioPortfolio

CIR is here to help companies solve their problems and reach their goals. We like new ideas, modern ways of thinking. We won't work with companies unless we think we can help. We only take on projects where our goals are in line with those we work with. CIR set up and runs the high value, technology manufacturing event series (HVM Series). This is a powerful set of newstyle events with talks, expos, and marketplaces for technology companies, product makers and assemblers, and brand owners.

Location

United Kingdom

Contact

Phone: 44 1223 303500


News Articles [2011 Associated News Articles listed on BioPortfolio]

Bristol-Myers Squibb Co (BMY) Shares Bought by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. boosted its position in shares of Bristol-Myers Squibb Co by 4.7% in the first quarter, according to its most recent filing with the Securities and Exchange...

#jobs #lifescience MedImmune: Research Scientist – (Cambridge)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MedImmune: Research Scientist – (Cambridge) . Negotiable: MedImmune: Re...

AI company buys Cambridge research facility to accelerate its drug research

BenevolentAI, a private artificial intelligence company, has acquired a state-of-the-art drug discovery and development facility on the Babraham Research Campus in Cambridge, UK

Cambridge Uni launches £42m NHS care research institute

The University of Cambridge is launching a new, £42-million research institute, tasked with gathering evidence to better support decisions on improving NHS care and organisation.

Cambridge Analytica Suspends CEO After Alarming Reports On Its Election Maneuvers

Cambridge Analytica, the British political research group linked to President

#jobs #lifescience Controller Cambridge Healthcare

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Controller Cambridge Healthcare .MA-Boston, A Cambridge-based healthcare firm...

Cambridge Research Biochemicals supports evaluation of new Fuchs Dystrophy treatment

Cambridge Research Biochemicals has announced that under the terms of a new contract with Leidos Biomedical Research, it will support the evaluation of a new treatment approach for Fuchs Dystrophy

#jobs #lifescience AstraZeneca – Cambridge: Post Doc Fellow – in Cheminformatics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Post Doc Fellow – in Cheminformatics . N...

PubMed Articles [1139 Associated PubMed Articles listed on BioPortfolio]

GP leader urges government to step up investment.

Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.

The aim of this study was to perform a return-on-investment (ROI) analysis of a breast cancer screening program in Egypt by comparing net profit in treatment costs saved to program cost investment.

Translation research to apply genomics to improve health promotion: Is it worth the investment?

Rural and remote health research: Does the investment match the need?

To determine the percentage of research projects funded by the National Health and Medical Research Council in the period 2000-2014 that aimed specifically to deliver health benefits to Australians li...

General dependencies and causality analysis of road traffic fatalities in OECD countries.

The road traffic accidents were responsible for material and human loss which was equal to 2.8 to 5% of gross national product (GNP). However, literature does not explore the elasticity coefficients a...

Clinical Trials [1105 Associated Clinical Trials listed on BioPortfolio]

Determine Return on Investment in Heart Failure Remote Monitoring Program

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return ...

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

A three site study to evaluate the reproducibility of the Aina HbA1c Monitoring System in quantitative determination of glycosylated hemoglobin (HbA1c) took place at the following sites: ...

Color Vision as a Measure for Inherited Retinal Diseases

Background: - The purpose of this study is to find out whether color vision measured with the Cambridge Color Test is a good way to examine the severity of inherited retinal diseases (IRD...

Mother-Child Relationships During Pregnancy Among Bofi Foragers

This study will examine changes in mother-child relationships when mothers are pregnant, because this period may involve conflicts between mothers and children. A widely held evolutionary...

Mayo AVC Registry and BioBank

Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest or death i...

Companies [2392 Associated Companies listed on BioPortfolio]

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test ...

Cambridge Biomedical, Inc.

Cambridge Biomedical is a contract research organization (CRO) and diagnostic laboratory providing bioanalytical support to the pharmaceutical, biotechnology, and medical d...

Funxional Therapeutics Limited

Funxional Therapeutics is a privately held, clinical stage pharmaceutical company based in Cambridge (UK) which focuses on novel anti-inflammatory therapies. FXT is managed by a very experienced t...

Edison Investment Research

Edison Investment Research is Europe’s leading investment research company. The team of more than 70 includes over 40 analysts supported by a department of supervisory analys...

Funxional Therapeutics

Funxional Therapeutics is a privately held, clinical stage pharmaceutical company based in Cambridge (UK). The Company focuses on the discovery and development of novel anti-infla...

More Information about "Cambridge Investment Research Ltd" on BioPortfolio

We have published hundreds of Cambridge Investment Research Ltd news stories on BioPortfolio along with dozens of Cambridge Investment Research Ltd Clinical Trials and PubMed Articles about Cambridge Investment Research Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge Investment Research Ltd Companies in our database. You can also find out about relevant Cambridge Investment Research Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record